- Clinical Assistant Professor, Global Health
- Senior Research Scientist, Kenya Medical Research Institute, Nairobi, Kenya
Select from the following:
Dr. Bhavna Chohan received her PhD (Virology) from University of Washington and MSc degree from London School of Hygiene & Tropical Medicine, UK. She has worked with HIV/STI research since 1993, for collaborative research projects with UW/Nairobi in Kenya. After her graduate studies at UW under the mentorship of Dr. Overbaugh, she returned to Nairobi, Kenya in 2007, where she established molecular virology research laboratory and transferred technology of HIV early infant diagnosis and HIV drug resistance testing. Dr. Chohan's broad goals are to establish and implement quality research on HIV transmission studies to improve health outcomes in Kenya and build a resource of well-trained and qualified laboratory scientists in the country. Currently, she continues to serve as Laboratory Director for UW collaborative research studies in Nairobi and conducts funded research studies as lead and co-investigator for NIH and local (Kenya) funded studies, and supervises, trains and mentors students and junior scientists. Dr. Chohan is also a member of National AIDS & STI Control Program in Kenya and continues to attend HIV Prevention and PrEP Technical Working meetings and provide input on national guidelines for ART and PrEP implementation. Her research interests are focused on HIV transmission and drug resistance studies and to implement Laboratory strengthening and capacity building in the low and middle income (LMIC) countries in Africa.
- PhD, University of Washington
- MSc, London School of Hygiene & Tropical Medicine (UK)
- Child and Adolescent Health (incl. Pediatrics)
- HIV Transmission
- Laboratory Strengthening
- STDs (other than HIV)
Chohan BH, Ronen K, Khasimwa B, Matemo, D, Osborn L, Unger JA, Drake AL, Beck IA, Frenkel LM, Kinuthia J, John-Stewart G. Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment. PLoS One. 2021 Aug 18;16(8):e0256249. doi: 10.1371/journal.pone.0256249.
Chohan B, Tapia K, Benki-Nugent S, Khasimwa B, Nga’yo M, Maleche-Obimbo E, Wamalwa D, Overbaugh J, John-Stewart G. Nevirapine resistance in previously NVP-unexposed HIV-1 infected infants initiating early antiretroviral therapy. AIDS Res Hum Retroviruses. 2015;31(8):783-91. PMCID: PMC4533021.
Chohan BH, Tapia K, Merkel, M, Kariuki A, Khasimwa B, Olago A, Gichuhi R, Obimbo EM, and Wamalwa D. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children. J Acquir Immune Defic Syndr. 2013;63(3):e87-93. doi: 10.1097/QAI. 0b013e318292f9cd. PMCID: PMC3767042.
Piantadosi A*, Chohan B*, Chohan V, McClelland S, Overbaugh J. Chronic HIV-1 infection Fails to Protect against Superinfection. PloS Pathogens. 2007;3(11):e177. (*co-first authors). PMCID: PMC2077901.
Baeten J.Chohan B, Lavreys L, Chohan, V R. McClelland S, Certain L, Mandaliya K, Jaoko w, Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression compared with subtype A in spite of similar HIV-1 plasma viral loads. J Infect Dis. 2007 Apr 15;195(8):1177-80. PMID: 17357054.